Indivior | Crediti Commerciali



Trade Debtors Cambiamento Data
AstraZeneca USD 14.83B 1.28B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Glaxosmithkline GBP 7.32B 542M 2024-12
Halozyme Therapeutics USD 308.46M 22.71M 2024-12
Indivior 271M 10M 2024-09
J&J USD 14.84B 1.33B 2024-12
Kyowa Hakko Kirin JPY 157.02B 16.2B 2024-12
Merck USD 11.12B 1.06B 2024-12
Novartis USD 7.56B 594M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Sanofi 8.8B 2.24B 2024-06
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12



Indivior Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.